Abstract: There are disclosed certain 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-one compounds of formula (I), and pharmaceutically acceptable salts thereof, together with compositions containing them and their use in therapy. The compounds are inhibitors of the enzyme MPO and are thereby particularly useful in the treatment or prophylaxis of cardiovascular disorders such as heart failure and coronary artery disease related conditions.

Abstract: An “odorless drain assembly” comprises an outer cylinder (23) with an open top wall, and an inner cylinder (21); said outer cylinder (23) is connected with the inner cylinder (21) by a common base (22); and a gap (D) is formed in between; said outer cylinder (23) is extended with an outer edge curled down and around as a lip portion (24); and a perforated sleeve (30) covers up said inner cylinder (21) with an open bottom wall extended with an outer edge curled up (U-shape) and around as a stopper ring (31). The diameter of said perforated sleeve (30) is larger than the inner cylinder (21) but smaller than the outer cylinder (23); thereby separate inner gap (D1) and outer gap (D2) are divided from the gap (D); further a plurality of pores (32) formed at the lower half portion of a side wall of the perforated sleeve (30).